白宫官员：232关税与药品命令无关。

Core Viewpoint - The White House officials clarified that the Section 232 tariffs are not related to the recent drug pricing orders [1] Group 1 - The Section 232 tariffs are primarily focused on national security concerns rather than healthcare policies [1] - The administration aims to separate trade policy from healthcare initiatives to avoid confusion [1] - Officials emphasized that the drug pricing orders are part of a broader strategy to lower prescription costs for Americans [1]